Monday, 2 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual Report

Concord Biotech Annual Report

Concord Biotech Ltd filed its Annual Report for FY 2025-26. The report covers corporate overview, management reports, and financial statements ending March 31, 2026.

Source

BSE filing, NSE: CONCORDBIO. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Concord Biotech Ltd: key numbers

Share price
₹1,163.50
Market cap
₹12,172 Cr
Revenue (annual)
₹1,055 Cr
Net profit (annual)
₹260.9 Cr
P/E (TTM)
43.1×Sector 45.9×
Promoter holding
44.09%+0.01% QoQ
FII holding
7.28%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Concord Biotech Ltd

All →

Other annual report announcements

All →